Literature DB >> 21267793

CD46 plasticity and its inflammatory bias in multiple sclerosis.

Siobhan Ni Choileain1, Anne L Astier.   

Abstract

Known as a link to the adaptive immune system, a complement regulator, a "pathogen magnet" and more recently as an inducer of autophagy, CD46 is the human receptor that refuses to be put in a box. This review summarizes the current roles of CD46 during immune responses and highlights the role of CD46 as both a promoter and attenuator of the immune response. In patients with multiple sclerosis (MS), CD46 responses are overwhelmingly pro-inflammatory with notable defects in cytokine and chemokine production. Understanding the role of CD46 as an inflammatory regulator is a distant goal considering the darkness in which its regulatory mechanisms reside. Further research into the regulation of CD46 expression through its internalization and processing will undoubtedly extend our knowledge of how the balance is tipped in favor of inflammation in MS patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21267793      PMCID: PMC4363543          DOI: 10.1007/s00005-010-0109-7

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  127 in total

1.  Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS.

Authors:  M Trojano; C Avolio; G M Liuzzi; M Ruggieri; G Defazio; M Liguori; M P Santacroce; D Paolicelli; F Giuliani; P Riccio; P Livrea
Journal:  Neurology       Date:  1999-10-22       Impact factor: 9.910

2.  Subtractive expression cloning reveals high expression of CD46 at the blood-brain barrier.

Authors:  Eric V Shusta; Chunni Zhu; Ruben J Boado; William M Pardridge
Journal:  J Neuropathol Exp Neurol       Date:  2002-07       Impact factor: 3.685

3.  CD46 is a cellular receptor for human herpesvirus 6.

Authors:  F Santoro; P E Kennedy; G Locatelli; M S Malnati; E A Berger; P Lusso
Journal:  Cell       Date:  1999-12-23       Impact factor: 41.582

4.  IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9.

Authors:  Jui-Hung Yen; Weimin Kong; Doina Ganea
Journal:  J Immunol       Date:  2010-02-26       Impact factor: 5.422

5.  Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid.

Authors:  J Mellergård; M Edström; M Vrethem; J Ernerudh; C Dahle
Journal:  Mult Scler       Date:  2009-12-09       Impact factor: 6.312

6.  ADAM-10 and ADAM-17 in the inflamed human CNS.

Authors:  Bernd C Kieseier; Heidrun Pischel; Eva Neuen-Jacob; Wallace W Tourtellotte; Hans-Peter Hartung
Journal:  Glia       Date:  2003-06       Impact factor: 7.452

7.  Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan.

Authors:  Peter H Larsen; Jennifer E Wells; William B Stallcup; Ghislain Opdenakker; V Wee Yong
Journal:  J Neurosci       Date:  2003-12-03       Impact factor: 6.167

Review 8.  Presenilin diversifies its portfolio.

Authors:  Annette L Parks; Daniel Curtis
Journal:  Trends Genet       Date:  2007-02-05       Impact factor: 11.639

9.  CD46-induced immunomodulatory CD4+ T cells express the adhesion molecule and chemokine receptor pattern of intestinal T cells.

Authors:  Shannon K Alford; Gregory D Longmore; William F Stenson; Claudia Kemper
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

10.  Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis.

Authors:  Maria V Tejada-Simon; Ying C Q Zang; Jian Hong; Victor M Rivera; Jingwu Z Zhang
Journal:  Ann Neurol       Date:  2003-02       Impact factor: 10.422

View more
  8 in total

Review 1.  CD46 processing: a means of expression.

Authors:  Siobhan Ni Choileain; Anne L Astier
Journal:  Immunobiology       Date:  2011-07-13       Impact factor: 3.144

2.  Role of autophagy in the pathogenesis of multiple sclerosis.

Authors:  Peizhou Liang; Weidong Le
Journal:  Neurosci Bull       Date:  2015-08-08       Impact factor: 5.203

3.  Characterization of the Regulation of CD46 RNA Alternative Splicing.

Authors:  Sze Jing Tang; Shufang Luo; Jia Xin Jessie Ho; Phuong Thao Ly; Eling Goh; Xavier Roca
Journal:  J Biol Chem       Date:  2016-05-12       Impact factor: 5.157

4.  Dysregulated CD46 shedding interferes with Th1-contraction in systemic lupus erythematosus.

Authors:  Ursula Ellinghaus; Andrea Cortini; Christopher L Pinder; Gaelle Le Friec; Claudia Kemper; Timothy J Vyse
Journal:  Eur J Immunol       Date:  2017-05-22       Impact factor: 5.532

Review 5.  Regulatory T cells in multiple sclerosis and myasthenia gravis.

Authors:  K M Danikowski; S Jayaraman; B S Prabhakar
Journal:  J Neuroinflammation       Date:  2017-06-09       Impact factor: 8.322

6.  Altered Expression of Complement Regulatory Proteins CD35, CD46, CD55, and CD59 on Leukocyte Subsets in Individuals Suffering From Coronary Artery Disease.

Authors:  Nitesh Mishra; Madhav Mohata; Rajeev Narang; R Lakshmy; Anjali Hazarika; R M Pandey; Nibhriti Das; Kalpana Luthra
Journal:  Front Immunol       Date:  2019-08-29       Impact factor: 7.561

Review 7.  Intracellular complement - the complosome - in immune cell regulation.

Authors:  Giuseppina Arbore; Claudia Kemper; Martin Kolev
Journal:  Mol Immunol       Date:  2017-06-07       Impact factor: 4.407

Review 8.  Real-state of autophagy signaling pathway in neurodegenerative disease; focus on multiple sclerosis.

Authors:  Mehdi Hassanpour; Fateme Hajihassani; Amirataollah Hiradfar; Nasser Aghamohammadzadeh; Reza Rahbarghazi; Nasser Safaie; Mohammad Nouri; Yunes Panahi
Journal:  J Inflamm (Lond)       Date:  2020-02-11       Impact factor: 4.981

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.